No products in the cart.
Eli Lilly’s top dealmaker says don’t be surprised to see more M&A that pushes Lilly into new areas
2026-06-03
In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT Jacob Van Naarden is busy. In addition to running Eli Lilly‘s oncology business, he’s nowContinue Reading








